Brief: FDA Issues Warning Letter To VPR Brands LP, D/B/A Krave Nic
18/08/2022 15:47
Aug 18 (Reuters) - FDA :
* FDA ISSUES WARNING LETTER TO VPR BRANDS, LP D/B/A KRAVE
NIC
* FDA -CENTER FOR TOBACCO PRODUCTS REVIEWED KRAVENIC.COM,
DETERMINED NICOTINE GUMMY PRODUCTS LISTED ARE MANUFACTURED,
OFFERED FOR SALE TO U.S. CUSTOMERS
* FDA - REVIEW OF KRAVENIC.COM REVEALED THAT VPR BRANDS
MANUFACTURES, SELLS SOME NICOTINE GUMMY PRODUCTS WITHOUT A
MARKETING AUTHORIZATION ORDER IN U.S.
Further company coverage: VPRB.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VPR Brands LP
See all newsBrief: Vpr Brands Acquires Cartdub Setting New Standards In Cannabis And Hemp Oil Recovery
Brief: VPR Brands AnnounceS Its Uplisting From Pink Sheets To OTCQB Venture Market
Brief: FDA Issues Warning Letter To VPR Brands LP, D/B/A Krave Nic
Brief: VPR Brands Announces Q1 Revenue Of $1.25 Mln
Brief: Vpr Brands Says May Seek A Buyer For Co's U.S. Utility Patent For Electronic Cigarette Number 8205622 In Future